发明名称 BONE AND/OR JOINT DISEASE-ASSOCIATED GENE
摘要 <p>It is intended to provide a method of acquiring a gene inhibiting cartilage differentiation which comprises forcibly expressing a transcriptional factor in a cell lacking the transcriptional factor (preferably forcibly expressing Runx2/Cbfa1 in a chondrocyte lacking Runx2/Cbfa1), and acquiring a gene the expression of which is thus induced by the DNA chip method, the subtraction method or the like; and a chondrocyte lacking Runx2/Cbfa1 which is needed in performing the above method. It is also intended to provide a polynucleotide obtained by the above method; a polypeptide encoded by the polynucleotide; an antibody against the polypeptide; a recombinant vector containing the polynucleotide; a transformant having the recombinant DNA vector; a cell expressing the polypeptide; a transgenic animal having the polynucleotide; a model animal of bone and/or joint diseases (preferably arthritis derformans); a method of screening a remedy and/or a preventive for bone and/or joint diseases (preferably arthritis derformans) by using the above susbtance(s); a candidate compound for a remedy and/or a preventive selected by this method; and a medicinal composition and a diagnostic method for bone and/or joint diseases (preferably arthritis derformans).</p>
申请公布号 WO2005038022(A1) 申请公布日期 2005.04.28
申请号 WO2004JP15879 申请日期 2004.10.20
申请人 TEIJIN PHARMA LIMITED;KOMORI, TOSHIHISA;KANATANI, NAOKO;YOSHIDA, CAROLINA ANDREA;ZANMA, AKIRA;KOBAYASHI, SHINJI;YAMANA, KEI 发明人 KOMORI, TOSHIHISA;KANATANI, NAOKO;YOSHIDA, CAROLINA ANDREA;ZANMA, AKIRA;KOBAYASHI, SHINJI;YAMANA, KEI
分类号 A61K38/00;C07K14/47;C12Q1/68;(IPC1-7):C12N15/00;C12N5/10;C07K14/46;A61P19/00;A61K38/17 主分类号 A61K38/00
代理机构 代理人
主权项
地址